Phibro Animal Health Corp. (PAHC) Sees Large Volume Increase
Phibro Animal Health Corp. (NASDAQ:PAHC) saw unusually-high trading volume on Thursday . Approximately 146,197 shares changed hands during mid-day trading, a decline of 3% from the previous session’s volume of 151,029 shares.The stock last traded at $20.98 and had previously closed at $20.65.
PAHC has been the topic of several research reports. Guggenheim reissued a “buy” rating and issued a $26.00 price objective (down from $34.00) on shares of Phibro Animal Health Corp. in a research report on Friday, May 13th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $42.00 target price on shares of Phibro Animal Health Corp. in a research report on Monday, April 11th. Zacks Investment Research raised Phibro Animal Health Corp. from a “sell” rating to a “hold” rating in a research report on Thursday, April 7th. Macquarie reaffirmed a “hold” rating on shares of Phibro Animal Health Corp. in a research report on Tuesday, April 19th. Finally, TheStreet lowered Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research report on Thursday, June 9th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. Phibro Animal Health Corp. presently has a consensus rating of “Hold” and an average price target of $35.33.
The firm’s 50 day moving average is $19.57 and its 200 day moving average is $24.14. The stock has a market capitalization of $810.21 million and a PE ratio of 10.54.
Phibro Animal Health Corp. (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, May 9th. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.43 by $0.05. During the same quarter in the prior year, the company posted $0.41 EPS. The firm had revenue of $183 million for the quarter, compared to analyst estimates of $197.24 million. The firm’s quarterly revenue was down 2.1% compared to the same quarter last year. On average, equities research analysts anticipate that Phibro Animal Health Corp. will post $1.60 EPS for the current year.
In related news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction dated Thursday, May 19th. The shares were acquired at an average cost of $18.14 per share, for a total transaction of $90,700.00. Following the acquisition, the director now directly owns 10,000 shares in the company, valued at approximately $181,400. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Other institutional investors recently bought and sold shares of the company. Russell Frank Co boosted its position in Phibro Animal Health Corp. by 256.6% in the fourth quarter. Russell Frank Co now owns 34,144 shares of the company’s stock valued at $1,049,000 after buying an additional 24,568 shares in the last quarter. Cornerstone Capital Management Holdings LLC. boosted its stake in shares of Phibro Animal Health Corp. by 95.6% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 87,620 shares of the company’s stock worth $2,640,000 after buying an additional 42,820 shares in the last quarter. Foresters Investment Management Company Inc. boosted its stake in shares of Phibro Animal Health Corp. by 8.4% in the fourth quarter. Foresters Investment Management Company Inc. now owns 953,775 shares of the company’s stock worth $28,737,000 after buying an additional 74,100 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Phibro Animal Health Corp. by 92.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 269,740 shares of the company’s stock worth $8,128,000 after buying an additional 129,660 shares in the last quarter.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.